Screener
Neuropace, Inc. NPCE EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s EBIT?
- Neuropace, Inc. (NPCE) reported EBIT of -$5.14M in Q2 2026.
- How has Neuropace, Inc.'s EBIT changed year-over-year?
- Neuropace, Inc.'s EBIT increased by 37.2% year-over-year, from -$8.19M to -$5.14M.
- What is the long-term trend for Neuropace, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s EBIT has grown at a -7.1% compound annual growth rate (CAGR), from -$23.74M to -$17.7M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Neuropace, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude